GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) PLUS ERYTHROPOIETIN (EPO) FOR THE MAINTENANCE TREATMENT OF THE ANEMIA OF MYELODYSPLASTIC SYNDROMES (MDS)

被引：0
|
作者：
NEGRIN, RS
STEIN, R
DOHERTY, K
CORNWELL, J
VARDIMAN, J
KRANTZ, S
GREENBERG, PL
机构：
[1] STANFORD UNIV,STANFORD,CA 94305
[2] VANDERBILT UNIV,NASHVILLE,TN
[3] UNIV CHICAGO,CHICAGO,IL 60637
来源：
EXPERIMENTAL HEMATOLOGY | 1994年 / 22卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：703 / 703
页数：1
相关论文
共 50 条
  • [1] GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) PLUS ERYTHROPOIETIN (EPO) TREATMENT OF MYELODYSPLASTIC SYNDROMES
    NEGRIN, RS
    DOHERTY, K
    STEIN, R
    VARDIMAN, J
    KRANTZ, S
    GREENBERG, PL
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 745 - 745
  • [2] GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND ERYTHROPOIETIN (EPO) THERAPY IN PEARSONS SYNDROME (PS)
    SHOFFNER, JM
    FLEMING, WH
    KRAWIECKI, N
    YEAGER, AM
    WALLACE, DC
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1051 - 1051
  • [3] Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients
    Miller, K
    LEUKEMIA RESEARCH, 1998, 22 : S13 - S16
  • [4] COMBINATION THERAPY WITH ALL-TRANS-RETINOIC ACID (ATRA), GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF), ERYTHROPOIETIN (EPO) AND VITAMIN-E IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    GANSER, A
    OTTMANN, OG
    SCHADECKGRESSEL, C
    KOLBE, K
    HAAS, R
    SEIPELT, G
    MAURER, A
    ZANDER, C
    REUTZEL, R
    HOELZER, D
    BLOOD, 1993, 82 (10) : A377 - A377
  • [5] TREATMENT OF THE ANEMIA OF MYELODYSPLASTIC SYNDROMES USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN COMBINATION WITH ERYTHROPOIETIN
    NEGRIN, RS
    STEIN, R
    VARDIMAN, J
    DOHERTY, K
    CORNWELL, J
    KRANTZ, S
    GREENBERG, PL
    BLOOD, 1993, 82 (03) : 737 - 743
  • [6] Treatment of anemia in myelodysplastic syndrome (MDS) with darbepoetin-alpha (DPO) and granulocyte colony stimulating factor (G-CSF).
    Rose, SS
    Ali, Y
    Maffei, B
    Saidi, P
    BLOOD, 2005, 106 (11) : 303B - 304B
  • [7] GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN FOR THE ANEMIA OF MYELODYSPLASTIC SYNDROMES - A REAL IMPROVEMENT WITH RESPECT TO ERYTHROPOIETIN ALONE
    MUSTO, P
    FALCONE, A
    CAROTENUTO, M
    CATALANO, L
    CENNAMO, A
    ROTOLI, B
    BLOOD, 1994, 84 (05) : 1687 - 1688
  • [8] GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TREATMENT DECREASES THE EXPRESSION OF GRANULOCYTE ALLOANTIGENS
    STRONCEK, D
    CLAY, M
    HERR, G
    MCCULLOUGH, J
    TRANSFUSION, 1994, 34 (10) : S77 - S77
  • [9] GUIDELINES FOR THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)
    HARVEY, V
    EVANS, B
    THOMPSON, P
    NEW ZEALAND MEDICAL JOURNAL, 1995, 108 (1006) : 349 - 349
  • [10] A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    HELLSTROMLINDBERG, E
    BIRGEGARD, G
    CARLSSON, M
    CARNESKOG, J
    DAHL, IM
    DYBEDAL, I
    GRIMFORS, G
    MERK, K
    TANGEN, JM
    WINQVIST, I
    OST, A
    LEUKEMIA & LYMPHOMA, 1993, 11 (3-4) : 221 - 228
12345